Purchase Order HHSN272201200145P
- Not listed
- This federal contract award to Illumina, Inc. in the amount of $14,112.00 was issued by the National Institute of Allergy and Infectious Diseases (NIAID) within the National Institutes of Health (NIH). The contract is a firm fixed-price purchase order with no set-aside designation. Illumina, a manufacturer of genetic sequencing instruments and reagents, is providing a range of sequencing systems, consumables, and support services under this award to support genomic research and analysis across...
- This is a federal contract award to Illumina, Inc., a manufacturer of genetic analysis and sequencing equipment, by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH). The contract is for the delivery of Illumina reagents and consumables, with a ceiling value of $13,750. It is a firm fixed price delivery order contract with no set-aside designation. Illumina has previously been awarded other prime federal contracts and...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and reagents. The $3,938.22 firm fixed price purchase order is for the delivery of sequencing kits, with a completion date of September 14, 2015. The contract has no set-aside designation. Illumina has a history of providing sequencing systems, reagents, and...
- This is a federal purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. The $8,734 firm fixed-price contract is for the delivery of Illumina's sequencing systems, reagents, and related services to support genomic research and analysis. Illumina is a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract has no set-aside designation....
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. The $5,636.16 contract is for the delivery of Illumina's sequencing systems, reagents, and services to support genomic research and analysis. Illumina, a manufacturer of genetic analysis instruments and consumables, has previously been awarded prime contracts and sub-awards across various federal agencies...
- This federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH), was issued to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $24,385.03 firm fixed price purchase order does not have a set-aside designation. The award supports Illumina's provision of goods and services related to genomic sequencing and analysis, potentially for research and...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions. The $3,409.10 contract is for the provision of sequencing systems, reagents, consumables, and related support services to support genomic research and diagnostics. Illumina has a history of prior prime federal contract and...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $4,638.33 contract is for Illumina reagent kits to support the agency's research and diagnostic needs. Illumina has a history of providing sequencing systems, reagents, and bioinformatics products to federal agencies like the CDC,...
- This is a federal contract award to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The award, valued at $10,331.78, is a delivery order placed under a larger federal contract vehicle. The award is for Illumina to provide sequencing systems, reagents, and related services to support genomic sequencing and analysis for the National Human Genome Research Institute, which is part of the National Institutes of Health (NIH), a civilian agency. The...
- This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. The contract has a ceiling value of $3,161.60 and is for the provision of Illumina's sequencing systems, reagents, and related services to support genomic sequencing and analysis for research and diagnostic applications. The contract does not have a set-aside designation. Based on Illumina's history...
This is a federal contract award to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $4,266.00, was awarded by the National Institutes of Health (NIH) and the National Institute of Allergy and Infectious Diseases (NIAID) for the purchase of various Illumina sequencing systems, reagents, and related services. The contract is a firm fixed-price purchase order with no set-aside designation. Illumina has received multiple federal contract and subcontract awards from agencies such as the NIH, CDC, USDA, and VA to support genomic sequencing and analysis for research and diagnostic purposes. This award appears to be part of a larger federal program managed by the NIAID Acquisitions Office to procure Illumina's proprietary sequencing technology and services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 12/30/11 |